Clinical Trials Logo

Clinical Trial Summary

This is an exploratory study to determine the safety and clinical benefit of OMS302 Injection in subjects undergoing Cataract Extraction with Lens Replacement (CELR) using a coaxial phacoemulsification process.


Clinical Trial Description

OMS302 Injection is a mydriatic/anti-inflammatory combination investigational drug product being developed as an irrigation solution during intracameral lens replacement surgical procedures of the eye. OMS302 irrigation solution may induce and maintain an adequately dilated pupil and reduce postoperative symptoms of discomfort such as eye pain and irritation. The use of OMS302 irrigation solution may eliminate the need for pre-operative dilation of the eye and could reduce the postoperative use of an anti-inflammatory and pain medications following surgery. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00721695
Study type Interventional
Source Omeros Corporation
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 2008
Completion date February 2009

See also
  Status Clinical Trial Phase
Completed NCT00924729 - Study of Ocular Penetration of Topically Administered Fluoroquinolones Phase 4
Completed NCT00521456 - A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery Phase 3
Completed NCT00524264 - A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery Phase 3
Completed NCT00565695 - Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction N/A
Completed NCT02973880 - Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction Phase 3
Withdrawn NCT00466908 - Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery
Completed NCT00366665 - Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems N/A
Completed NCT05571683 - Cerebral Oxymeter and End Tidal Carbondioxide Values Under Surgical Drapes With and Without Past COVID-19 Infection
Not yet recruiting NCT04977115 - Clinical Evaluation of Intraocular Caliper-assisted Capsulotomy for Age-related Cataract N/A
Withdrawn NCT00366613 - Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation Phase 4
Completed NCT00366496 - Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens N/A
Not yet recruiting NCT03828500 - Preoperative Fasting for Ambulatory Cataract Surgery: The PRACTICE Study N/A
Completed NCT00840580 - Effect on Wound Healing of Vigamox Versus Cravit Phase 4
Completed NCT00842231 - Assessment of Visual Performance in Patients With Low Levels of Astigmatism N/A
Completed NCT00851760 - Epiretinal Macular Membrane and Cataract Extraction N/A
Recruiting NCT03944070 - Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery N/A
Completed NCT03364972 - A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00 N/A
Completed NCT00824070 - Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects Phase 1
Completed NCT00366587 - Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs Phase 4
Completed NCT00366691 - Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation Phase 4